ANUH PHARMA Financial Statement Analysis
|
||
|
The Revenues of ANUH PHARMA have increased by 2.24% YoY .
The Earnings Per Share (EPS) of ANUH PHARMA has decreased by -21.12 % YoY. |
||
ANUH PHARMA Last 5 Annual Financial Results
[BOM: 506260|NSE : ANUHPHR]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹662 Cr | ₹647 Cr | ₹527 Cr | ₹487 Cr | ₹432 Cr |
| Expenses | ₹600 Cr | ₹571 Cr | ₹476 Cr | ₹439 Cr | ₹387 Cr |
| Operating Profit (Excl OI) | ₹62 Cr | ₹76 Cr | ₹52 Cr | ₹47 Cr | ₹45 Cr |
| Other Income | ₹9.46 Cr | ₹12 Cr | ₹6.12 Cr | ₹5.20 Cr | ₹11 Cr |
| Interest | ₹1.24 Cr | ₹0.96 Cr | ₹0.75 Cr | ₹1.58 Cr | ₹2.03 Cr |
| Depreciation | ₹8.74 Cr | ₹8.58 Cr | ₹9.70 Cr | ₹12 Cr | ₹15 Cr |
| Profit Before Tax | ₹61 Cr | ₹78 Cr | ₹47 Cr | ₹39 Cr | ₹39 Cr |
| Profit After Tax | ₹47 Cr | ₹60 Cr | ₹36 Cr | ₹31 Cr | ₹28 Cr |
| Earnings Per Share (Rs) | ₹9.45 | ₹11.98 | ₹7.22 | ₹6.10 | ₹5.67 |
| PAT Margin (%) | 7.10 | 9.24 | 6.83 | 6.22 | 6.46 |
| ROE(%) | 15.34 | 22.56 | 15.90 | 15.11 | 16.12 |
| ROCE(%) | 19.77 | 29.66 | 21.05 | 19.33 | 19.75 |
| Total Debt/Equity(x) | 0.03 | 0.01 | 0.00 | 0.01 | 0.07 |
Key Financials |
||
| Market Cap | : | ₹ 831.6 Cr |
| Revenue (TTM) | : | ₹ 767.7 Cr |
| Net Profit(TTM) | : | ₹ 41.8 Cr |
| EPS (TTM) | : | ₹ 4.2 |
| P/E (TTM) | : | 19.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ANUH PHARMA | 4% | 6.7% | -16.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -1.5% | -2.6% |
| DIVIS LABORATORIES | 5.5% | -0.2% | 0.8% |
| CIPLA | 1.3% | -7.9% | -6.6% |
| TORRENT PHARMACEUTICALS | 2.1% | 2.8% | 30.9% |
| DR REDDYS LABORATORIES | 2% | 4.5% | 2.3% |
| MANKIND PHARMA | 0.2% | -6.3% | -16.6% |
| ZYDUS LIFESCIENCES | -0.8% | 0.3% | -9.3% |
| LUPIN | -0.4% | 0.9% | 0.8% |
ANUH PHARMA Revenues
[BOM: 506260|NSE : ANUHPHR]
| Y-o-Y | 2.24 % |
| 5 Yr CAGR | 11.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹662 Cr | 2.24 | |
| Mar2024 | ₹647 Cr | 22.66 | |
| Mar2023 | ₹527 Cr | 8.39 | |
| Mar2022 | ₹487 Cr | 12.66 | |
| Mar2021 | ₹432 Cr | - | |
ANUH PHARMA Operating Profit
[BOM: 506260|NSE : ANUHPHR]
| Y-o-Y | -18.77 % |
| 5 Yr CAGR | 8.07 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹62 Cr | -18.77 | |
| Mar2024 | ₹76 Cr | 46.24 | |
| Mar2023 | ₹52 Cr | 9.14 | |
| Mar2022 | ₹47 Cr | 5.20 | |
| Mar2021 | ₹45 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -20.58 % |
| 5 Yr CAGR | -2.87 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 9.3% | -20.58 | |
| Mar2024 | 11.71% | 19.25 | |
| Mar2023 | 9.82% | 0.72 | |
| Mar2022 | 9.75% | -6.70 | |
| Mar2021 | 10.45% | - | |
ANUH PHARMA Profit After Tax
[BOM: 506260|NSE : ANUHPHR]
| Y-o-Y | -21.16 % |
| 5 Yr CAGR | 13.60 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | -21.16 | |
| Mar2024 | ₹60 Cr | 66.00 | |
| Mar2023 | ₹36 Cr | 18.39 | |
| Mar2022 | ₹31 Cr | 7.47 | |
| Mar2021 | ₹28 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -23.16 % |
| 5 Yr CAGR | 2.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 7.1 % | -23.16 | |
| Mar2024 | 9.24 % | 35.29 | |
| Mar2023 | 6.83 % | 9.81 | |
| Mar2022 | 6.22 % | -3.72 | |
| Mar2021 | 6.46 % | - | |
ANUH PHARMA Earnings Per Share (EPS)
[BOM: 506260|NSE : ANUHPHR]
| Y-o-Y | -21.12 % |
| 5 Yr CAGR | 13.62 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.45 | -21.12 | |
| Mar2024 | ₹12 | 65.93 | |
| Mar2023 | ₹7.22 | 18.36 | |
| Mar2022 | ₹6.10 | 7.58 | |
| Mar2021 | ₹5.67 | - | |
ANUH PHARMA Return on Capital Employed (ROCE)
[BOM: 506260|NSE : ANUHPHR]
| Y-o-Y | -33.34 % |
| 5 Yr CAGR | 0.03 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 19.77% | -33.34 | |
| Mar2024 | 29.66% | 40.90 | |
| Mar2023 | 21.05% | 8.90 | |
| Mar2022 | 19.33% | -2.13 | |
| Mar2021 | 19.75% | - | |
ANUH PHARMA Share Price vs Sensex
| Current Share Price | : | ₹83.0 |
| Current MarketCap | : | ₹ 831.6 Cr |
| Updated EOD on | : | Feb 11,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 4% |
6.7% |
-16.1% |
| SENSEX | 0.5% |
0.8% |
7.2% |
ANUH PHARMA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 2.4% | -1.1% | 1.5% |
| BSE SMALLCAP | -5.8% | -8.9% | -10.5% |
No NSE index found
You may also like the below Video Courses
FAQ about ANUH PHARMA Financials
How the annual revenues of ANUH PHARMA have changed ?
The Revenues of ANUH PHARMA have increased by 2.24% YoY .
How the Earnings per Share (EPS) of ANUH PHARMA have changed?
The Earnings Per Share (EPS) of ANUH PHARMA has decreased by -21.12 % YoY .
Check out Intrinsic Value of Peers of ANUH PHARMA
Compare Stock Analytics of Peers of ANUH PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
